Atlas Trials

NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes

Clinical trial NCT00013910 · COMPLETED

Trial details

NCT number
NCT00013910
Sponsor
National Center for Research Resources (NCRR)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Non-Insulin-Dependent
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.